Package 45802-626-26

Brand: cetirizine hydrochloride

Generic: cetirizine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 45802-626-26
Digits Only 4580262626
Product NDC 45802-626
Product ID 45802-626_2263eac3-aa51-4b35-8535-db7e21cf5660
Description

1 BOTTLE in 1 CARTON (45802-626-26) / 120 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2008-07-24
Brand cetirizine hydrochloride
Generic cetirizine hydrochloride
Sample Package No

Linked Drug Pages (1)

Cetirizine Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2263eac3-aa51-4b35-8535-db7e21cf5660", "openfda": {"unii": ["64O047KTOA"], "rxcui": ["1014673"], "spl_set_id": ["2f47dbc5-dfb4-425c-9fe4-777fa3c4e72e"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (45802-626-26)  / 120 mL in 1 BOTTLE", "package_ndc": "45802-626-26", "marketing_start_date": "20080724"}], "brand_name": "Cetirizine Hydrochloride", "product_id": "45802-626_2263eac3-aa51-4b35-8535-db7e21cf5660", "dosage_form": "SOLUTION", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "45802-626", "generic_name": "Cetirizine hydrochloride", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cetirizine Hydrochloride", "active_ingredients": [{"name": "CETIRIZINE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA078398", "marketing_category": "ANDA", "marketing_start_date": "20080724", "listing_expiration_date": "20261231"}